These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Azadbakht L, Atabak S, Esmaillzadeh A. Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902 [Abstract] [Full Text] [Related]
4. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Chen ST, Ferng SH, Yang CS, Peng SJ, Lee HR, Chen JR. Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576 [Abstract] [Full Text] [Related]
5. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia. Ristić Medić D, Ristić V, Arsić A, Postić M, Ristić G, Blazencić Mladenović V, Tepsić J. Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698 [Abstract] [Full Text] [Related]
7. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Velasquez MT, Bhathena SJ, Ranich T, Schwartz AM, Kardon DE, Ali AA, Haudenschild CC, Hansen CT. Kidney Int; 2003 Dec; 64(6):2100-7. PubMed ID: 14633132 [Abstract] [Full Text] [Related]
8. Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss and lipid levels in overweight adults. Liao FH, Shieh MJ, Yang SC, Lin SH, Chien YW. Nutrition; 2007 Dec; 23(7-8):551-6. PubMed ID: 17574819 [Abstract] [Full Text] [Related]
11. The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Jenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, Faulkner DA, Vidgen E, Greaves KA, Paul G, Singer W. Arch Intern Med; 2009 Jun 08; 169(11):1046-54. PubMed ID: 19506174 [Abstract] [Full Text] [Related]
14. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients. Nart A, Uslu A, Bozkaya G, Aykas A, Dogan M, Karaca B. Transplant Proc; 2009 Mar 08; 41(2):751-5. PubMed ID: 19328972 [Abstract] [Full Text] [Related]
15. [Treatment with pravastatin of dyslipidemia associated with diabetic nephropathy]. Robles NR, Ruiz-Calero R, Coronado M, Escola JM, Sánchez Casado E. An Med Interna; 1998 Nov 08; 15(11):572-5. PubMed ID: 9882852 [Abstract] [Full Text] [Related]
16. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction. Nakano R, Kurosaki E, Shimaya A, Kajikawa S, Shibasaki M. Eur J Pharmacol; 2006 Nov 07; 549(1-3):185-91. PubMed ID: 16989806 [Abstract] [Full Text] [Related]